BiotechTube
Home/Eternygen/Prof. Jens Jordan
PJ

Prof. Jens Jordan

Scientific Founder

Eternygen

Therapeutic Areas

Metabolic DiseasesNon-alcoholic Fatty Liver Disease (NAFLD/NASH)Chronic Kidney DiseaseType 2 DiabetesObesityOsteoporosis

Eternygen Pipeline

DrugIndicationPhase
SLC13A5 Inhibitor ProgramMetabolic Diseases (NAFLD/NASH, CKD, Diabetes, Obesity)Pre-clinical
SLC13A5 Modulator ProgramAge-Related Bone Loss / OsteoporosisPre-clinical

Leadership Team at Eternygen

PA
Prof. Andreas Birkenfeld
Scientific Founder
MJ
Marco Janezic
CEO & Co-Founder
DG
Dr. Grit Zahn
Head of Science
DC
Dr. Christian Schetter
Chairman of the Board
View full Eternygen profile